BioWorld

Aug. 6, 2010

Analysis SORTs Out Blood Lipids, Heart Disease Risk

NewCo News: Sweden's BioChromix Pharma Tackles AD's Amyloid Cascade

Alexza Slides on $18M Stock Offering, PDUFA Date Ahead

Alexza Pharmaceuticals Inc. is raising $18 million in a registered direct offering of stock and warrants, news that sent shares of the Mountain View, Calif.-based firm falling 18 percent Thursday. (BioWorld Today) Read More

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors

Today's news in brief

BioWorld

BioWorld briefs for June 10, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

BioWorld Science

Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.

Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors

BioWorld Science

Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...

BioWorld

Aug. 6, 2010

Analysis SORTs Out Blood Lipids, Heart Disease Risk

NewCo News: Sweden's BioChromix Pharma Tackles AD's Amyloid Cascade

Other News To Note

Stock Movers

Clinic Roundup

Appointments And Advancements

Earnings Roundup

Alexza Slides on $18M Stock Offering, PDUFA Date Ahead

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors

Today's news in brief

News in brief

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors